Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) -25.97M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 19,100
Avg Vol 38,660
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 15%
Beta N/A
Analysts Strong Sell
Price Target N/A

Company Profile

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tu...

Industry: Biotechnology
Sector: Healthcare
Phone: (678) 384-7220
Fax: (678) 384-7281
Address:
1900 Lake Park Drive, Suite 380, Smyrna, United States
Latest News on GOVXW
No data available.